logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jochen Seufert

university of freiburg medical center

55H-index
636Paper Count
1.9WCitation Count
Published Papers 153
Publication Date
logo
How does survodutide work? Plain language review of a potential new medication for obesity and liver disease
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-06-05
err0
PREAI
errJaime P Almandoz; Alexander Dimitri Miras; Jochen Seufert; Elizabeth Paul
errShare
errSave
Weight Loss Strategies Associated With Type 2 Diabetes Duration: A Population-Based Optimal Intervention Window From the NHANES
errJournal of Diabetes Research
IF3.4
err2026-04-27
err0
errOAAI
errMaximilian Andreas Storz; Roman Huber; Jochen Seufert
errShare
errSave
Obesity: novel pharmacological treatments
errDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
IF0.7
err2026-03-01
err0
PREAI
errSeufert, Jochen
errShare
errSave
GLP-1 receptor agonists or SGLT2-inhibitors? Evaluation of a personalized treatment algorithm for individuals with type 2 diabetes: a registry-based cohort study
errEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
IF1.7
err2026-03-01
err0
PREAI
errMori, Tim; Kuss, Oliver; Mader, Julia K.; Naudorf, Michael; Seufert, Jochen; Holl, Reinhard W.; Lanzinger, Stefanie; Grimsmann, Julia M.
errShare
errSave
Dear reader
errDiabetologie und Stoffwechsel
IF0
err2026-02-01
err0
PREAI
errGallwitz, Baptist; Mussig, Karsten; Ritzel, Robert A.; Seufert, Jochen; Weigert, Cora
errShare
errSave
Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM study
errdiabetes, obesity and metabolism
IF0
err2026-01-20
err0
errOAAI
errStefan Pscherer MD; Andreas Fritsche MD; Helmut Anderten MD; Katrin Pegelow PhD; Henry Y. Han MD; Martin Pfohl MD; Jochen Seufert MD
errShare
errSave
Effects of Empagliflozin in Heart Failure Patients with Type 2 Diabetes: A Biomarker Perspective
errEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
IF1.7
err2025-11-01
err0
PREAI
errElrakaybi, Asmaa; Zhou, Qian; Path, Gunter; Hug, Martin; Seufert, Jochen; Laubner, Katharina
errShare
errSave
Experience diversity, build networks - young scientists at the Diabetes Congress 2025
errDIABETOLOGIE UND STOFFWECHSEL
IF0
err2025-10-01
err0
PREAI
errLiu, Sijia Anna; Krupka, Sontje; Laaser, Jonas; Drozd, Irena; Woitek, Cornelia; Seufert, Jochen
errShare
errSave
Vaccinations in Patients with Diabetes: Current Recommendations
errDiabetologie und Stoffwechsel
IF0
err2025-10-01
err0
PREAI
errSeufert, Jochen; Schwarz, Peter E. H.; Blueher, Matthias; Gallwitz, Baptist; Schelling, Joerg
errShare
errSave
Interdisciplinary strategies for the prevention and treatment of MASLD
errDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
IF0.7
err2025-10-01
err0
PREAI
errRohlen, Natascha; Laubner, Katharina; Seufer, Jochen; Thimme, Robert
errShare
errSave
Ring Augmentation and Pouch Resizing for the Treatment of Dumping Syndrome After Roux-en-Y Gastric Bypass: A Prospective Single-Center Trial
errObesity Surgery
IF3.1
err2025-09-22
err0
errOAAI
errJodok Matthias Fink; Mareike Luehn; Maximilian Meyer-Steenbuck; Gabriel Seifert; Sephan Herrmann; Stefan Fichtner-Feigl; Jochen Seufert; Goran Marjanovic; Katharina Laubner
errShare
errSave
Indication-based vaccinations for people with diabetes mellitus
errDIABETOLOGIE
IF0
err2025-09-01
err1
PREAI
errGallwitz, Baptist; Muller-Wieland, Dirk; Wanner, Christoph; Schwarz, Peter; Girndt, Matthias; Kleophas, Werner; Bluher, Matthias; Seufert, Jochen
errShare
errSave
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study
errDIABETOLOGIA
IF10.2
err2025-05-22
err0
errOAAI
errHeni, Martin; Fruehwald, Lisa; Karges, Wolfram; Naudorf, Michael; Niemoeller, Kathrin; Pagnia, Frank; Reindel, Joerg; Seufert, Jochen; Ufer, Gisa; Wagner, Christian; Holl, Reinhard W.; Prinz, Nicole
errShare
errSave
Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type-2 diabetes and chronic kidney disease: DPV registry study
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-02-19
err0
errOAAI
errVijayan, Anjaly; Lanzinger, Stefanie; Forestier, Nicole; Hess, Gregor; Rottmann, Marcus; Wosch, Frank J.; Seufert, Jochen; Holl, Reinhard W.; Bramlage, Peter
errShare
errSave
Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-01-06
err0
PREAI
errSeufert, Jochen; Wiesner, Tobias; Pegelow, Katrin; Kenzler, Julia; Pfohl, Martin
errShare
errSave
Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-12-27
err0
PREAI
errBaechle, Christina; Rosenbauer, Joachim; Stahl-Pehe, Anna; Seufert, Jochen; Mader, Julia K.; Wagner, Christian; Wosch, Frank-Juergen; Erath, Dieter; Holl, Reinhard W.; Lanzinger, Stefanie; DPV Sci Initiative; German Ctr Diabetes Res DZD
errShare
errSave
Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-10-08
err3
errOAAI
errFerone, Diego; Freda, Pamela; Katznelson, Laurence; Gatto, Federico; Kadioglu, Pinar; Maffei, Pietro; Seufert, Jochen; Silverstein, Julie M.; Spencer-Segal, Joanna L.; Isaeva, Elena; Dreval, Alexander; Harrie, Maria; Svedberg, Agneta; Tiberg, Fredrik
errShare
errSave
Reduce d bone mineral density is associated to post-TIPS survival of female patients with decompensated cirrhosis
errDIGESTIVE AND LIVER DISEASE
IF3.8
err2024-10-01
err0
errOAAI
errReincke, Marlene; Seufert, Jochen; Laubner, Katharina; Meyer-Steenbuck, Maximilian; Dammer, Anna; Sturm, Lukas; Thimme, Robert; Bettinger, Dominik; Schultheiss, Michael
errShare
errSave
Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-07-09
err0
errOAAI
errAuzanneau, Marie; Seufert, Jochen; Zimny, Stefan; Haak, Thomas; Zeyfang, Andrej; Goelz, Stefan; Hugenberg, Inge; Pavel, Marianne; Rosenbauer, Joachim; Holl, Reinhard W.
errShare
errSave
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial
errEUROPEAN JOURNAL OF HEART FAILURE
IF10.8
err2024-06-26
err1
PREAI
errVaduganathan, Muthiah; Cannon, Christopher P.; Jardine, Meg J.; Heerspink, Hiddo J. L.; Arnott, Clare; Neuen, Brendon L.; Sarraju, Ashish; Gogate, Jagadish; Seufert, Jochen; Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W.; Kosiborod, Mikhail N.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
D
Diederick E. Grobbee
H-index: 162 · Papers: 1.2K
C
Christopher P. Cannon
H-index: 154 · Papers: 1.4K
C
Christos S. Mantzoros
H-index: 142 · Papers: 960
C
Charis Eng
H-index: 139 · Papers: 1.2K
View more